126 related articles for article (PubMed ID: 2658539)
1. Dose-ranging antiemetic trial of high-dose oral metoclopramide.
Tyson LB; Gralla RJ; Kris MG; Young CW; Clark RA
Am J Clin Oncol; 1989 Jun; 12(3):239-43. PubMed ID: 2658539
[TBL] [Abstract][Full Text] [Related]
2. Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy.
Strum SB; McDermed JE; Opfell RW; Riech LP
JAMA; 1982 May; 247(19):2683-6. PubMed ID: 7043002
[TBL] [Abstract][Full Text] [Related]
3. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Kelsen DP; Reilly LK; Groshen S; Bosl GJ; Kalman LA
Cancer; 1985 Feb; 55(3):527-34. PubMed ID: 3880660
[TBL] [Abstract][Full Text] [Related]
4. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
[TBL] [Abstract][Full Text] [Related]
5. Oral metoclopramide with or without diphenhydramine: potential for prevention of late nausea and vomiting induced by cisplatin.
Grunberg SM; Ehler E; McDermed JE; Akerley WL
J Natl Cancer Inst; 1988 Aug; 80(11):864-8. PubMed ID: 3392746
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Gilbert CJ; Ohly KV; Rosner G; Peters WP
Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
[TBL] [Abstract][Full Text] [Related]
7. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
[TBL] [Abstract][Full Text] [Related]
8. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
Gebbia V; Testa A; Valenza R; Cannata G; Tirrito ML; Gebbia N
Cancer; 1995 Nov; 76(10):1821-8. PubMed ID: 8625054
[TBL] [Abstract][Full Text] [Related]
9. Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research.
Support Care Cancer; 1994 May; 2(3):167-70. PubMed ID: 8032702
[TBL] [Abstract][Full Text] [Related]
10. Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation.
Strum SB; McDermed JE; Pileggi J; Riech LP; Whitaker H
Cancer; 1984 Mar; 53(6):1432-9. PubMed ID: 6692333
[TBL] [Abstract][Full Text] [Related]
11. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176
[TBL] [Abstract][Full Text] [Related]
12. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
Roila F
Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.
Köseoglu V; Kürekçi AE; Sarici U; Atay AA; Ozcan O
Eur J Pediatr; 1998 Oct; 157(10):806-10. PubMed ID: 9809818
[TBL] [Abstract][Full Text] [Related]
14. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
15. Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis.
Roila F; Basurto C; Bracarda S; Sassi M; Lupattelli M; Picciafuoco M; Boschetti E; Tonato M; Del Favero A
Eur J Cancer; 1991; 27(2):119-21. PubMed ID: 1827271
[TBL] [Abstract][Full Text] [Related]
16. Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.
Allen JC; Gralla R; Reilly L; Kellick M; Young C
J Clin Oncol; 1985 Aug; 3(8):1136-41. PubMed ID: 4020411
[TBL] [Abstract][Full Text] [Related]
17. Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.
Cleri LB; Kris MG; Tyson LB; Pisters KM; Clark RA; Gralla RJ
Cancer; 1995 Sep; 76(5):774-8. PubMed ID: 8625179
[TBL] [Abstract][Full Text] [Related]
18. Combination antiemetics for cisplatin chemotherapy.
Sridhar KS; Donnelly E
Cancer; 1988 Apr; 61(8):1508-17. PubMed ID: 3280112
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
20. [Recent improvements in antiemetic therapy].
Roila F; Palladino MA; Ciccarese G; Basurto C
Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
